Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma

Published:2016-02-02 Issue:1 Volume:15 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Schrödter Sarah,Braun Martin,Syring Isabella,Klümper Niklas,Deng Mario,Schmidt Doris,Perner Sven,Müller Stefan C,Ellinger Jörg

Funder

Deutsche Gesellschaft für Urologie

Rudolf-Becker-Stiftung

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-016-0495-5.pdf

Reference32 articles.

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. European journal of cancer (Oxford, England : 1990). 2013;49(6):1374-403. Epub 2013/03/15. doi: 10.1016/j.ejca.2012.12.027 . PubMed

2. King SC, Pollack LA, Li J, King JB, Master VA. Continued Increase in Incidence of Renal Cell Carcinoma, Especially in Young Patients and High Grade Disease: United States 2001 to 2010. J Urol. 2014. Epub 2014/01/16. doi: 10.1016/j.juro.2013.12.046 . PubMed

3. La Rochelle J, Wood C, Bex A. Refining the use of cytoreductive nephrectomy in metastatic renal cell carcinoma. Semin Oncol. 2013;40(4):429–35. doi: 10.1053/j.seminoncol.2013.05.007 . Epub 2013/08/27. PubMed.

4. Albiges L, Choueiri T, Escudier B, Galsky M, George D, Hofmann F, et al. A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer. Eur Urol. 2014. doi: 10.1016/j.eururo.2014.04.006 . Epub 2014/05/21. PubMed.

5. Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, et al. The Reactome pathway knowledgebase. Nucleic acids research. 2014;42(Database issue):D472-7. Epub 2013/11/19. doi: 10.1093/nar/gkt1102 . PubMed PMID: 24243840; PubMed Central PMCID: PMCPmc3965010.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning;PLOS ONE;2024-06-10

2. Identification of key genes CCL5, PLG, LOX and C3 in clear cell renal cell carcinoma through integrated bioinformatics analysis;2023-12-21

3. Role of tumor necrosis factor alpha-induced protein 6 (TNFAIP6) in tumors: A pan-cancer analysis;Oncology and Translational Medicine;2023-12-15

4. Identification of a novel anoikis-related gene signature and molecular subtype to predict prognosis and tumor microenvironment in clear cell renal cell carcinoma;2023-10-17

5. Single-cell RNA sequencing identifies SLC6A3 as a biomarker and prognostic marker in clear cell renal cell carcinoma;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3